Inventor

Frank Mattner

Inventor
Vienna, AT

Overview

22→
Patents
1999–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides16%
C12NMicroorganisms or enzymes6%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
Y02ATechnologies for adaptation to climate change6%
A61MDevices for introducing media into, or onto, the body3%
C07HSugars1%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
PatentTitleYear
11,065,273Treatment and prevention of alzheimer's disease (AD)202110,646,565Treatment of alzheimer'S disease (AD) with an aluminum salt202010,478,454Treatment of Alzheimer's disease (AD) with aluminum oxyhydroxide201910,344,062Method of inhibiting C5a20199,625,459'Method for diagnosing alzheimer\'s disease (AD)'20179,457,078'Methods for inhibiting C5a with C5a peptides coupled or fused to a carrier protein'20169,029,327'Vaccine'20158,900,564'Vaccine composition comprising an antigen and a peptide having adjuvant properties'20148,618,046'Treatment of atherosclerosis with cholesterol ester transport protein mimotopes'20138,613,931'Compounds for treating beta-amyloidoses'20138,361,476'Vaccine composition comprising an antigen and a peptide having adjuvant properties'20138,277,815'Pharmaceutical composition comprising an antigen'20128,022,180'Method for preventing and treating Alzheimer\'s disease'20117,935,252'Methods of treating Alzheimer\'s Disease with an apheresis device'20117,935,348'Combination therapy for the treatment of Alzheimer\'s disease'20117,732,568'Methods for preventing and treating Alzheimer\'s disease'20107,658,928'Method of vaccination comprising administering an antigen and a cathelicidin derived antimicrobial peptide'20107,528,223'Antigens encoded by alternative reading frames from pathogenic viruses'20097,378,234'Method for isolating hepatitis C virus peptides'20087,244,438'Uses for polycationic compounds'20077,148,191'Antigenic composition'20065,928,636'Use of IL-12 and IFN.alpha. for the treatment of infectious diseases'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999Based in Mailand, IT· patent location history
2006–2013Patents assigned to INTERCELL AG (7)· patent assignee history
2006–2021Based in Vienna, AT· patent location history
2011Patents assigned to AFFIRIS FORSCHUNGS UND ENTWICKLUNGS GMBH (3)· patent assignee history
2012–2016Patents assigned to MATTNER FRANK (7)· patent assignee history
2012–2014Patents assigned to BUSCHLE MICHAEL (3)· patent assignee history
2013–2021Patents assigned to AFFIRIS AG (9)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AFFIRIS AG92013–2021
INTERCELL AG72006–2013
MATTNER FRANKself72012–2016
AFFIRIS FORSCHUNGS UND ENTWICKLUNGS GMBH32011
BUSCHLE MICHAEL32012–2014
Locations
LocationPatentsSpan
Vienna, AT212006–2021
Mailand, IT11999